#United States #Cambridge #Roche #Ellis Bio #SuperMethyl

Introduction

In the rapidly advancing field of methylation sequencing, Ellis Bio's innovative SuperMethyl™ kits have recently received acclaim in a new Tech Spotlight published by Roche. These findings highlight the promising capabilities of the SuperMethyl™ Max and Fast kits, which exhibit superior performance in low-input cell-free DNA (cfDNA) workflows. Roche's evaluation reveals that these products not only match but also exceed the gold standards set by other established methods, providing researchers with dependable and high-quality data essential for studying gene regulation, cancer, and various diseases.

Key Findings from Roche's Evaluation

The independent evaluation conducted by Roche presents several key findings regarding the new SuperMethyl™ kits:
1. Exceptional Methylation Calling Accuracy: The SuperMethyl™ Max kit achieved the highest accuracy in methylation calling, significantly reducing false-positive results compared to both traditional bisulfite conversion methods and leading enzymatic methyl-seq techniques.
2. High Conversion Efficiency: The study found that the SuperMethyl™ Max kit delivered an impressive 99.8% C-to-T conversion for both cfDNA and genomic DNA (gDNA), showcasing its effectiveness in low-input scenarios. Similarly, the SuperMethyl™ Fast kit returned a conversion efficiency of approximately 99.7%, making it an excellent choice for labs seeking rapid results.
3. Lowest False-Positive Rate: The evaluation highlighted that the SuperMethyl™ Max kit produced remarkably low false-positive rates, with only 0.18% on cfDNA and 0.15% on gDNA. This performance was at least four times better than that of the NEBNext enzymatic methods.
4. Enhanced Library Yields and Coverage: SuperMethyl™ Max generated approximately 1.8 times higher gDNA library yields and provided 19% deeper mean coverage compared to traditional methods. This is particularly critical in fields such as liquid biopsy and minimal residual disease research, where sample quality and integrity matter.

Implications for Researchers

The results of Roche's evaluation come as a significant boon for researchers and clinicians focused on developing next-generation methylation assays. The integration of Ellis Bio's SuperMethyl™ kits into workflows promises to streamline and enhance the accuracy of methylation profiling:

• - Scalable Solutions: Researchers can rely on these kits to effectively process fragile and low-input samples without undergoing substantial adjustments to their existing protocols.
• - Enhanced Research Output: Given the high conversion efficiencies and reduced error rates, researchers can expect consistent and reliable results, paving the way for new discoveries in cancer research and epigenetics.

Innovations Behind the SuperMethyl™ Kits

At the heart of these advancements is Ellis Bio's proprietary Ultra-Mild Bisulfite Sequencing (UMBS) chemistry, which minimizes DNA damage during the methylation conversion process. This technology underpins both SuperMethyl™ Max and SuperMethyl™ Fast kits, ensuring that researchers can focus on their primary studies without compromising data quality due to technical limitations.

Moreover, SuperMethyl™ kits are designed to integrate seamlessly into established NGS workflows, particularly in conjunction with Roche's KAPA EvoPrep® library preparation platform. This integration facilitates a streamlined process, enhancing both efficiency and accuracy in methylation sequencing applications.

Conclusion

Ellis Bio’s SuperMethyl™ Max and Fast kits are revolutionizing the landscape of low-input methylation sequencing. By offering enhanced accuracy, speed, and compatibility, these products provide invaluable resources for researchers seeking to unravel the complexities of DNA methylation in health and disease. As the demand for precision in genomic research grows, tools like the SuperMethyl™ kits are poised to lead the charge into a future of ground-breaking discoveries in epigenetics and beyond.

For those interested in exploring these advancements further, a detailed report can be accessed through Ellis Bio’s website. The evaluation underscored not only the scientific rigor of these products but also Illustrated their potential impact on the broad field of genetic research and diagnostics.